Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116444382B introduces a scalable aqueous iodination method for high-purity 4-iodo-2-methylaniline, ensuring cost reduction and supply reliability.
Patent CN113121462B reveals a metal-free, safe route for 5-trifluoromethyl-1,2,3-triazoles. Discover cost-effective manufacturing and supply chain advantages.
Patent CN113307778A reveals a novel Mo/Cu co-catalyzed route for 3-trifluoromethyl-1,2,4-triazoles, offering cost reduction in API manufacturing and scalable production.
Patent CN118878543A reveals high-purity axial chiral synthesis. Delivers significant cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN118619879A reveals a novel Rh-catalyzed route for trifluoromethyl enaminones, offering high purity and scalable supply chain solutions for pharmaceutical intermediates.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply and cost reduction.
Patent CN114539198B reveals a novel Pd-catalyzed synthesis route offering significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Discover a novel one-step synthesis for polysubstituted thiopyran derivatives using ZnCl2 catalysis. Enhance your API intermediate supply chain with cost-effective, high-purity solutions.
Patent CN112898192B details a novel palladium-catalyzed carbonylation method for N-acyl indoles, offering cost reduction in API manufacturing and scalable production.
Patent CN108409615B discloses a green route for chiral sulfinamides, eliminating liquid ammonia usage and enhancing yield for reliable pharmaceutical intermediate supply chains.
Novel patent CN117209411A offers a short-route synthesis for indole aldehydes. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Advanced isolation method boosts purity to 98.4%. Reduces costs and ensures supply continuity for immunosuppressant manufacturing.
Patent CN112239436A details a novel Pd-catalyzed bis-carbonylation route for 4-acyl-2(5H)-furanones, offering high yields and simplified supply chains for API manufacturing.
Patent CN114539198B reveals a novel Pd-catalyzed route for chroman amides. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel carbonylation method using sulfonyl chloride offers high yields and broad substrate scope for reliable API intermediate manufacturing.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Cost-effective, scalable route for API intermediates without heavy metals.
Patent CN113105402B reveals a metal-free iodine-promoted route for high-purity triazole synthesis, offering significant cost reduction and scalable manufacturing for global API supply chains.
Patent CN113511986B enables catalyst-free aryl acetonitrile production. Delivers high purity pharmaceutical intermediates with simplified supply chain and cost efficiency.
Novel nickel-catalyzed method reduces cost and toxicity for alpha beta unsaturated amide manufacturing supply chain reliability and efficiency significantly for buyers.
Patent CN115215814A details a robust Rh-catalyzed route to isoxazolidines, offering cost reduction in API manufacturing and reliable supply chain solutions.